Gain Therapeutics, Inc. (GANX) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts GANX Hot Sheet
Join SI Premium – FREE
Gain Therapeutics, Inc. (NASDAQ: GANX) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Gain Therapeutics, Inc. (GANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- DA Davidson Starts Armstrong World Industries (AWI) at Neutral
- Faraday Future cancels 237,615 warrants from March 2025 financing
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
